about
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)Applications of urinary proteomics in biomarker discoverySpecific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells.Potential new urinary markers in the early detection of bladder cancer.Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer.Aminopeptidase activities as prospective urinary biomarkers for bladder cancer.ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A ReviewLong interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potentialDeveloping urinary metabolomic signatures as early bladder cancer diagnostic markersUrinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.Detection of bladder cancer using novel DNA methylation biomarkers in urine sedimentsRationale for an early detection program for bladder cancerBladder cancer determination via two urinary metabolites: a biomarker pattern approachEffects of three commonly-used diuretics on the urinary proteome.A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database.Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancerProfilin 1 is a potential biomarker for bladder cancer aggressivenessUrine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.Metabolomics in bladder cancer: a systematic review.Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer.Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids.Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.Urothelial carcinoma of the bladder: definition, treatment and future efforts.Recent advances in urinary bladder cancer detection.High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.Contemporary diagnosis of bladder cancer.Republished: non-invasive urine based tests for the detection of bladder cancer.The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.Noninvasive approaches for detecting and monitoring bladder cancer.Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and futurDownregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics.Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis.Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria.The role of collecting bladder wash fluid before biopsy procedure to help the cytological diagnosis of residual tumor.Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.The clinical significance of class III (suspicious) urine cytology.
P2860
Q26744756-E41FD6FC-4527-4DBE-B93C-3E26CACFDE73Q27010368-2AFA78AB-C8EB-4F6C-9E59-C587F765BFA2Q31039602-7BBB8255-0A7A-4BA1-AEA3-FEDAFCD3EF06Q33657098-402A1C43-46D4-4972-962E-8DE79D490CB6Q33739794-BAED1AE0-ED2A-408F-9C07-BE042BC4D97CQ33762931-9F50850D-6EA7-4D47-941A-831DCD70BFC9Q33820634-CAEADCCE-BE36-46D3-A22B-5B88190CA2D6Q34277612-7F5FA2FC-BC4E-4018-B9FD-1FFF54C51FF5Q34802622-7E44CD3C-1A03-4DE2-8194-9B0F26BB15C7Q34987865-AF514C39-32CF-47F4-B1F8-ABC6A6DDF292Q35093755-F0584A48-5934-42CA-AC33-A14397131F35Q35125733-E4410B45-DE72-4125-A1AF-B2CF601F80FBQ35497484-38C65D3C-4ECF-4401-B609-D7958F8FB725Q35543587-05E2B5D4-552F-47EE-9FC1-3BBCB5CEEC09Q35579632-F08C277D-7C02-4E74-A4AF-E6634660065FQ35650689-EEB1EC90-2235-45E4-B2FB-B492C13CF5E0Q35878733-6FEC7D79-FCA2-4A43-AB9C-D1473E5E34CFQ35966060-680DCA5F-4C14-4CCB-8D41-4B85BCDBFE6CQ36046441-23A1437F-4E86-49E0-A7DE-006A0D648D8DQ36085915-C4F4BC2A-9630-4949-8982-444D977D3178Q36190604-8D077353-586B-4239-B12E-7709412BBC4AQ37406847-614AB98E-955E-440B-BC48-63F0279EEA46Q37739690-6A1C003C-5BBC-4B01-865C-94F20F423C8DQ37810251-C8B6464C-ED96-4D8F-8364-7F46CD0B3BD4Q37818317-3DA75E0C-058D-4950-B13A-91A02FAF915FQ37944437-73D78ABF-4957-4756-BA6D-0F1BB7DC9AFCQ38030593-9526F236-5434-4C5A-BD88-E601A350534DQ38052445-C50C2291-F2CF-4FD4-A074-0CBC3F294614Q38089768-AED6395B-6A8A-41A6-9921-F976FDC07E55Q38107899-A6EBA1F8-B072-433F-88DC-B5A4A4BE11D0Q38285466-8CC7FC05-7004-42E0-A8D8-B0148F2D4A80Q38286089-A0DC9D21-6EB7-4E71-9BEB-E8CD3D940076Q38342245-165E2406-0ADC-4678-B270-256F566E6A6DQ38874857-664A70BB-007F-4377-8D39-C04511CB1EDFQ38963399-D53A1183-3927-4B6B-9604-532502A66045Q39359483-786309A5-9F73-4606-93EC-459C35F09D35Q39763864-B0BB27CE-5FD5-4BC9-97B8-21B7364DAB7DQ42407616-6B70A1C4-8C8B-49A2-84CE-5890BA78EFB2Q44204551-400F2218-5DA1-4DBD-9AE2-AA1AECBB8743Q44291379-1DC98743-C722-477C-A7BA-16656F8AF7AC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urinary markers in bladder cancer.
@en
Urinary markers in bladder cancer.
@nl
type
label
Urinary markers in bladder cancer.
@en
Urinary markers in bladder cancer.
@nl
prefLabel
Urinary markers in bladder cancer.
@en
Urinary markers in bladder cancer.
@nl
P1433
P1476
Urinary markers in bladder cancer.
@en
P2093
J Alfred Witjes
Olaf P J Vrooman
P304
P356
10.1016/J.EURURO.2007.12.006
P407
P577
2007-12-17T00:00:00Z